Sky Century Investment (SKYI) Change in Cash (2012 - 2026)

Sky Century Investment's (SKYI) quarterly Change in Cash came in at -$3096.0 in Q2 2026, down 127.37% year-on-year from $11312.0 in Q2 2025, and down 207.02% on a QoQ basis from $2893.0 in Q1 2026.

Sky Century Investment (SKYI) Change in Cash (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 5 years of Change in Cash data on file, last reported at -$3096.0 in Q2 2026.

  • On a quarterly basis, Change in Cash fell 127.37% year-over-year to -$3096.0 in Q2 2026; TTM through May 2026 was -$11048.0, a 197.67% decrease from a year earlier, with the FY2025 full-year figure at $477.0, changed N/A from the prior year.
  • Change in Cash for Q2 2026 stood at -$3096.0, down from $2893.0 in the prior quarter.
  • Over the last five years, Change in Cash for SKYI reached as high as $11312.0 in Q2 2025 and fell as low as -$10835.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 185.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -509.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -388.85 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -277.40 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 457.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -446.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -117.00 Mn
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 -3,096.00

Historic Data

Download Data
DateValue
May 31, 2026 -3,096.00
Feb 28, 2026 2,893.00
Nov 30, 2025 -10.00
Aug 31, 2025 -10,835.00
May 31, 2025 11,312.00
Feb 28, 2014 -5,050.00
Nov 30, 2013 5,086.00
Aug 31, 2013 325.00
Feb 28, 2013 -200.00
Aug 31, 2012 -4,146.00